AI Infrastructure & MLOps for Pharmaceuticals & Life Sciences

A model registry with versioned deployments is what lets you roll back in minutes. Without it, a bad model version becomes a very long evening.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how ai infrastructure & mlops has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is deviation and CAPA drafting, usually integrated against pharmacovigilance databases. Integration comes before intelligence. A model that cannot reach your systems of record is a demo with good manners.

Multi-model by default, so a provider outage is a routing decision rather than an incident. We hand over with runbooks, tests and a team that knows how it works, not a dependency.